NYSEAMERICAN:XTNT Xtant Medical (XTNT) Stock Price, News & Analysis $0.28 -0.03 (-9.52%) As of 10/23/2026 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsNews and TrendsOwnershipSEC Filings About Xtant Medical Stock (NYSEAMERICAN:XTNT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Xtant Medical alerts:Sign Up Key Stats Today's Range$0.28▼$0.3250-Day Range$0.28▼$0.4152-Week Range$0.27▼$0.95Volume84,638 shsAverage Volume129,460 shsMarket Capitalization$39.60 millionP/E RatioN/ADividend YieldN/APrice Target$1.00Consensus RatingBuy Company Overview Xtant Medical Holdings, Inc. is a medical technology company focused on developing, manufacturing and distributing products used in orthopedic and spinal procedures. Its portfolio is designed to support bone growth, spinal fusion and the repair or reconstruction of musculoskeletal structures. The company offers a range of biologic products, including human tissue allografts, demineralized bone matrix and other bone-graft substitutes. It also provides implantable devices and surgical instruments for spine and orthopedic applications, including products used in interbody fusion and spinal fixation procedures. Xtant Medical is headquartered in Belgrade, Montana, and serves the U.S. orthopedic and spine markets through direct sales and distribution relationships. The company was formerly known as Bacterin International Holdings and adopted the Xtant Medical name in 2015. Its products are used primarily by surgeons, hospitals and other healthcare providers.AI Generated. May Contain Errors. Read More Xtant Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks54th Percentile Overall ScoreXTNT MarketRank™: 2.702467149365 of 5 starsXtant Medical scored higher than 54% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingXtant Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and no sell ratings.Upside PotentialXtant Medical has a consensus price target of $1.00, representing about 254.2% upside from its current price of $0.28.Amount of Analyst CoverageXtant Medical has received no research coverage in the past 90 days.Read more about Xtant Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Xtant Medical is -3.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Xtant Medical is -3.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioXtant Medical has a P/B Ratio of 0.78. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Xtant Medical's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.11% of the float of Xtant Medical has been sold short.Short Interest Ratio / Days to CoverXtant Medical has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Xtant Medical has recently decreased by 46.58%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldXtant Medical does not currently pay a dividend.Dividend GrowthXtant Medical does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A Search Interest2 people have searched for XTNT on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Xtant Medical insiders have not sold or bought any company stock.Percentage Held by Insiders10.70% of the stock of Xtant Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions69.33% of the stock of Xtant Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Xtant Medical's insider trading history. Receive XTNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Xtant Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XTNT Stock News HeadlinesLucid Capital Markets initiates coverage of Xtant Medical Holdings (XTNT) with buy recommendationSeptember 3, 2026 | msn.comXtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental MarketAugust 27, 2026 | prnewswire.comTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery.October 25 at 1:00 AM | Behind the Markets (Ad)Xtant Medical (XTNT) Stock Forecast & Price TargetAugust 26, 2026 | investing.comXtant Medical Holdings (XTNT) Receives a Rating Update from a Top AnalystAugust 14, 2026 | theglobeandmail.comXtant Medical (XTNT) Q2 2026 Earnings Call TranscriptAugust 12, 2026 | finance.yahoo.comXtant Medical Holdings Corporate Event Calendar | AMEX:XTNTAugust 11, 2026 | benzinga.comXtant outlines $99M-$103M 2026 revenue guidance while integrating Dilon sales forceAugust 11, 2026 | seekingalpha.comSee More Headlines XTNT Stock Analysis - Frequently Asked Questions How have XTNT shares performed this year? Xtant Medical's stock was trading at $0.7840 at the beginning of 2026. Since then, XTNT shares have decreased by 64.0% and is now trading at $0.2823. How were Xtant Medical's earnings last quarter? Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) posted its quarterly earnings data on Tuesday, August, 11th. The medical device company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.05. The medical device company earned $23.03 million during the quarter, compared to analyst estimates of $24.88 million. Xtant Medical had a negative net margin of 10.17% and a negative trailing twelve-month return on equity of 23.45%. Read the conference call transcript. When did Xtant Medical's stock split? Xtant Medical's stock reverse split on the morning of Wednesday, February 14th 2018.The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 13th 2018. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. How do I buy shares of Xtant Medical? Shares of XTNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Xtant Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Xtant Medical investors own include Tonix Pharmaceuticals (TNXP), XTI Aerospace (XTIA), 22nd Century Group (XXII), Delcath Systems (DCTHD), Aptose Biosciences (APTO), Jaguar Animal Health (JAGX) and NVIDIA (NVDA). Company Calendar Last Earnings8/11/2026Today10/25/2026Next Earnings (Estimated)11/10/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 XTNT's financial health is in the Red zone, according to TradeSmith. XTNT has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSEAMERICAN:XTNT Previous SymbolAMEX:XTNT CIK1453593 Webxtantmedical.com Phone(406) 388-0480Fax406-388-1354Employees151Year Founded2006Price Target and Rating Average Price Target for Xtant Medical$1.00 High Price Target$1.00 Low Price Target$1.00 Potential Upside/Downside+254.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($0.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$4.97 million Net Margins-10.17% Pretax Margin-8.44% Return on Equity-23.45% Return on Assets-12.44% Debt Debt-to-Equity Ratio0.18 Current Ratio2.16 Quick Ratio1.05 Sales & Book Value Annual Sales$133.93 million Price / Sales0.30 Cash Flow$0.07 per share Price / Cash Flow3.88 Book Value$0.36 per share Price / Book0.78Miscellaneous Outstanding Shares140,290,000Free Float125,277,000Market Cap$39.60 million OptionableNot Optionable Beta-0.20 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSEAMERICAN:XTNT) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersWhy tech stocks are deadAI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the b...Porter & Company | Sponsored$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that l...Profits Run | SponsoredThe $100 Stock Behind Elon's Next MoveA small, publicly traded supplier trading under $100 a share has reportedly worked alongside Elon Musk for mor...Paradigm Press | SponsoredEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...Behind the Markets | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xtant Medical Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xtant Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
